baber/WOPTO huggingface dataset:
Patent EP-3946637-A1 (EP)
Title: Composition cosmetique pour cheveux
Inventor: BLONDEL FRÉDÉRIC
IPC: A61K8/81
Filed: 2020-03-16
Abstract: L'invention concerne une composition cosmétique aqueuse pour le soin et maintien des cheveux comprenant au moins une résine fixante, ladite résine comprenant au moins 20% molaire d'unité monomérique d'acide méthacrylique et/ou un de ses sels; et optionnellement au moins une unité monomérique d'acide acrylique et/ou d'anhydride maléique, et/ou un de leurs sels, la résine ayant un poids moléculaire moyen en poids supérieur ou égal à 20 000 g/mol. L'invention concerne également l'utilisation de la résine fixante pour améliorer la résistance à l'humidité de ces compositions cosmétiques.
Patent EP-3970032-A1 (EP)
Inventor: SIMHADRI HARSHA VARDHAN
IPC: G06F16/901
Filed: 2020-05-07
Abstract: The present disclosure relates to generating a search graph or search index to aid in receiving a search query and identifying results of a dataset based on the search query. For example, systems disclosed herein may generate a navigable search graph including vertices representative of objects or points within a dataset that enables a computing device having access to the search graph to navigate vertices of the graph along an identified path until arriving at a point within the search graph that corresponds to a value associated with the search query. Upon identifying a location within the graph corresponding to the search query, systems disclosed herein may identify a neighborhood of points (e.g., vertices) corresponding to items from the dataset and output a set of results for the search query representative of determined results for the search query.
Patent EP-3980076-A1 (EP)
Inventor: DELANEY JR JOSEPH THOMAS
IPC: A61K31/704
Filed: 2020-05-11
Abstract: A chemotherapy agent comprising a chemotherapy group and a ligand secured to the chemotherapy group is disclosed, the ligand comprising a reactive group capable of bonding to a capture substrate. A method of removing chemotherapy agents from a patient is disclosed, the method comprising providing a chemotherapy agent containing a reactive group; providing a capture substrate in contact with a patient's bloodstream; administering the chemotherapy agent to the patient; and sequestering the chemotherapy agent on the capture substrate. A system for removing chemotherapy agents is also disclosed.
Patent EP-3910079-A1 (EP)
Inventor: YAMAGATA RYUTARO
IPC: C22C38/60
Filed: 2020-01-08
Abstract: Grain-oriented electrical steel sheet excellent in magnetic properties and excellent in adhesion of the primary coating to the steel sheet is provided. The grain-oriented electrical steel sheet according to the present invention is provided with a base metal steel sheet containing a chemical composition containing, by mass%, C: 0.005% or less, Si: 0.5 to 7.0%, Mn: 0.05 to 1.00%, a total of S and Se: 0.005% or less, sol. Al: 0.005% or less, and N: 0.005% or less and having a balance comprised of Fe and impurities and with a primary coating formed on a surface of the base metal steel sheet and containing Mg<sub>2</sub>SiO<sub>4</sub> as a main constituent, wherein a peak position of Al emission intensity obtained when performing elemental analysis by glow discharge optical emission spectrometry from a surface of the primary coating in a thickness direction of the grain-oriented electrical steel sheet is arranged within a range of 2.0 to 12.0 µm from the surface of the primary coating in the thickness direction, and a number density of Al oxides of a size of 0.1 µm or more in terms of a circle equivalent diameter based on the area at the peak position of Al emission intensity is 0.03 to 0.2/µm<sup>2</sup>.
Patent EP-4007704-A1 (EP)
Title: Method for producing effect pigments
Inventor: HOFFMÜLLER WINFRIED
IPC: B42D25/445
Filed: 2020-07-27
Abstract: The invention relates to a method for producing platelet-shaped effect pigments (5), having the steps of: a) providing a carrier substrate (1); b) applying aqueous washable ink drops (2) onto the carrier substrate (1) in a controlled and printed manner in first regions (3) which form a first motif; c) applying a reflective coating (5, 6) onto the carrier substrate such that a reflective coating (6) is deposited on the carrier substrate (1) in the shape of a regular continuous grid in second regions (4) which form a second motif outside of the first regions (3) which form a first motif, wherein the first regions (3) which have the washable ink drops (2) and form a first motif form regular islands within the regular continuous grid, and a reflective coating (5) is deposited over the washable ink drops (2) in the first regions (3) which form a first motif; and d) removing the washable ink drops (2) in the first regions (3) together with the reflective coating (5) present thereon and isolating the removed reflective coating (5) in the form of platelet-shaped effect pigments (5).
Patent EP-4014340-A1 (EP)
Inventor: GROSSMANN MARCUS
IPC: H04B7/0456
Filed: 2020-08-07
Abstract: A communication device for providing channel state information, CSI, feedback in a wireless communication system is described. The communication device is to receive from a transmitter a radio signal via a time-variant, frequency-selective channel, the radio signal including reference signals according to a reference signal configuration comprising one or more ports, and signals comprising the reference signal configuration. The communication device is to estimate the channel using measurements on the reference signals on the radio channel, the reference signals provided over a configured number of frequency and time domain resources. The communication device is to select a precoder matrix {W), calculate either one or more of a channel quality indicator, CQI, and/or a precoder matrix indicator, PMI, and/or a rank indicator, Rl, using the explicit CSI and the precoder matrix (W), and report to the transmitter the CSI feedback including either one or more of the CQI, and/or the PMI and/or the Rl, wherein the PMI and Rl are used to indicate the precoder matrix for the configured frequency resources, time domain resources and one or more ports. The precoder matrix includes a single codebook comprising one or more Doppler-frequency components of the precoder, or two codebooks, a first codebook and a second codebook, wherein the first codebook comprises one or more Doppler-frequency components of the precoder, and wherein the second codebook comprises one or more delay components of the precoder or one or more spatial beam components of the precoder, or three codebooks, a first codebook, a second codebook and a third codebook, wherein the first codebook comprises one or more Doppler-frequency components of the precoder, wherein the second codebook comprises one or more delay components of the precoder, and wherein the third codebook comprises one or more spatial beam components of the precoder.
Patent EP-4189584-A1 (EP)
Inventor: MARTINEZ FERNANDO
IPC: G06V10/40
Filed: 2020-07-27
Abstract: A method of generating labeled training images for a machine learning system includes providing a set of labeled images, each of the labeled images in the set of labeled images depicting an instance of a type of object and comprising a label identifying the type of object, providing an unlabeled image including an instance of the object, generating bounding box coordinates for one or more bounding boxes around the instance of the object in the unlabeled image using the labeled images in the set of labeled images as templates, consolidating the one or more bounding boxes into a consolidated bounding box around the instance of the object in the unlabeled image, and labeling the consolidated bounding box according to the type of object to generate a labeled output image including bounding box coordinates of the consolidated bounding box.
Patent EP-4004556-A1 (EP)
Inventor: HARDING STEPHEN
IPC: G01N33/68
Filed: 2020-07-23
Abstract: An elution buffer for eluting one or more predetermined analytes from one or more analyte-specific antibodies or fragments thereof or for eluting one or more predetermined antibodies or fragments from a target antigen, wherein: the elution buffer has a pH of 1 to 5; and the elution buffer comprises a predetermined amount of an acid stable mass spectrometry ionisation control protein. The use of the elution buffer in the detection and quantifying of analytes, for example by mass spectrometry is also described.
Patent EP-4021347-A1 (EP)
Inventor: MÜLLER STEPHANIE
IPC: A61F2/16
Filed: 2020-08-07
Abstract: The invention relates to an intraocular lens (1) comprising an optical part (2), a haptic (5) which is coupled to the optical part (2), and an optical main axis (A) which passes through a front face (3) and a rear face (4) of the optical part (2), wherein the haptic (6) has at least one first haptic part (7) which is formed as a strand-like arm (8), and the strand-like arm (8) has a longitudinal axis (B). The strand-like arm (8) has at least one length adjusting device (11, 12), by means of which the length of the strand-like arm (8) can be adjusted in a defined manner in the direction of the longitudinal axis (B).
Patent EP-4010146-A1 (EP)
Title: Système et procédé de fabrication d'une pièce
Inventor: FERRY ALLAN
IPC: C21D1/42
Filed: 2020-07-16
Abstract: La présente invention concerne un système 10 permettant de fabriquer une pièce 12. Le système 10 comprend un portique 14, un premier bras mobile 22 et un second bras mobile 24, au moins un convoyeur 26, 28 et au moins un capteur 30, 32, 34, 36. Le portique 14 comprend un premier élément 16 et un second élément 18 disposé à l'opposé du premier élément 16 de manière à définir une ouverture 20. Les premier 22 et second 24 bras mobiles sont disposés respectivement sur les premier 16 et second 18 éléments. Le ou les convoyeurs 26, 28 sont conçus pour déplacer la pièce 12 à travers l'ouverture 20 de façon à positionner la pièce 12 à l'intérieur de l'accès des premier 22 et second 24 bras mobiles. Le ou les capteurs 30, 32, 34, 36 sont conçus pour guider les premier 22 et second 24 bras mobiles vers une ou plusieurs zones 38, 40, 42 de la pièce 12. Les premier 22 et second 24 bras mobiles sont conçus pour effectuer un processus de fabrication sur la pièce 12 au niveau de la ou des zones 38, 40, 42.
Patent EP-4025482-A1 (EP)
Inventor: PHILIPZIK FABIAN
IPC: B62M6/55
Filed: 2020-09-02
Abstract: L'invention concerne un dispositif de maintien (48) pour maintenir de manière amovible un accumulateur, en particulier un accumulateur de bicyclette, sur un cadre, en particulier sur un cadre de bicyclette, comprenant au moins une unité de support (14) pour recevoir et/ou guider au moins partiellement l'accumulateur. Selon l'invention, le dispositif de maintien (48) présente au moins une unité de verrouillage (18) qui est disposée sur l'unité de support (14), en particulier au moins principalement à l'intérieur du cadre, pour fixer de manière amovible l'accumulateur à l'unité de support (14), en particulier dans une direction axiale, sur un côté.
Patent EP-3940766-A1 (EP)
Inventor: WATANABE TSUYOSHI
IPC: H01L23/36
Filed: 2020-02-05
Abstract: An improvement in heat radiation efficiency is achieved.A semiconductor device according to the present technology includes a substrate portion on which a semiconductor chip is mounted and in which an external connection terminal for performing electrical connection to the outside is formed on a rear surface on a side opposite to a front surface which is a surface on a side where the semiconductor chip is mounted, an outer wall portion that protrudes toward the front surface side in an outer circumferential portion of the substrate portion, a lid portion which is supported by the outer wall portion and covers the semiconductor chip, and a heat storage member which is disposed at a position further inside than the outer wall portion between the rear surface of the substrate portion and a rear surface of the lid portion.
Patent EP-3924085-A1 (EP)
Inventor: FONTANA CHRISTOPHER D
IPC: B01D69/02
Filed: 2020-03-24
Abstract: Degassers, degassing systems, and methods of using degassers to remove gas molecules entrapped or dissolved in a processing liquid. The degasser has a vacuum chamber with one or more walls; one or multiple inlets and one or multiple outlets through which the liquid is respectively passed into and out of the vacuum chamber, the inlet(s) and the outlet(s) penetrating the one or more walls; one or multiple separators located inside the vacuum chamber and being pervious to the gas molecules but impervious to the liquid; at least one vacuum for applying through a vacuum port a pressure differential across the separator(s) to cause the gas molecules to leave the liquid and to permeate through the separator(s) thereby removing the entrapped or dissolved gas from the liquid; and optionally one or multiple feed lines in fluid communication with the inlet(s) and two or more than two separators.
Patent EP-3950117-A1 (EP)
Title: Blood purifier
Inventor: OISHI TERUHIKO
IPC: B01J20/28
Filed: 2020-03-27
Abstract: Provided is a blood purifier that comprises a porous molded body; that exhibits an excellent blood compatibility wherein platelet adherence is inhibited and exhibits a good cytokine adsorption capacity and a low pressure loss before and after blood treatment; and that can be safely used. Disclosed is a blood purifier that comprises a main vessel and a porous molded body housed in the main vessel. The porous molded body contains a hydrophobic polymer and a hydrophilic polymer. The amount of low-melting-point water per 1 g of dry weight of the porous molded body is 0.12 g to 2.00 g. The contact change ratio for the porous molded body is 0% to 0.2%. The ratio L/D is 1.00 to 2.30 where, for the region taken up by the porous molded body in the main vessel, L is the length in the flow direction and D is the circle-equivalent diameter of the cross section in the direction perpendicular to the flow direction. The circle-equivalent diameter D is calculated based on formula (A): D = 2√(V/L/3.14) (A). In formula (A), V is the apparent volume of the region taken up by the porous molded body in the main vessel. In addition, when an aqueous polyvinylpyrrolidone solution with a viscosity adjusted to 3.75 mPa·s to 3.85 mPa·s is flowed through the blood purifier at a flow-through rate of 400 mL/minute, the pressure loss of the blood purifier before blood treatment is less than 13 kPa and the pressure loss of the blood purifier after blood treatment is less than 13 kPa.
Patent EP-3949031-A1 (EP)
Title: Multi-diameter and multi-directional cable retaining assembly
Inventor: LANGE LUDWIG
IPC: H01R13/66
Filed: 2020-03-27
Abstract: A cable connector assembly includes lower and upper hood parts which are mated together to form a passageway therethrough in which a connector and a cable retaining assembly are mounted. The cable retaining includes a cable retaining body and a cable retainer attached thereto. The cable retaining body provides two exits and the cable retaining body can be positioned within the hood parts in a number of different orientations to change the exit path. Multiple cable retaining bodies and cable retainers can be interchangeably mounted within the hood parts.
Patent EP-4208353-A1 (EP)
Inventor: ALTINSOY FARUK
IPC: B60B7/01
Filed: 2020-09-02
Abstract: L'invention concerne un dispositif (3) pour protéger une jante de roue (2) d'un véhicule à moteur, dans lequel : un côté externe d'un bord de jante (4) est recouvert par le dispositif (3) ; le dispositif (3) comprend un anneau (5), dont le diamètre est adapté à celui du bord de jante (4) ; et l'anneau (5) a une languette circonférentielle (5.2) pour fixer le dispositif (3) au bord de jante (4), laquelle languette peut être serrée entre un côté interne du bord de jante (4) et une paroi latérale d'un pneu (1). Le dispositif (3) est destiné à être maintenu solidement sur la jante de roue (1) même à des vitesses très élevées et à des forces proportionnellement importantes agissant sur le dispositif (3). Aucune modification de la jante de roue (1) n'est nécessaire, et l'installation est simple. Pour ce faire, l'anneau unique (5) est produit à partir d'un matériau dur et a un espace radial continu (6), et des faces d'extrémité (5.3) de l'anneau formées par l'espace (6) peuvent être reliées au moyen d'une vis de serrage (8).
Patent EP-4059042-A1 (EP)
Inventor: LE BLANC YVES
IPC: H01J49/00
Filed: 2020-09-22
Abstract: In a DIA method, a specified precursor ion m/z range of interest is divided into a set of two or more precursor ion mass selection windows. A tandem mass spectrometer is instructed to select, dissociate using a first dissociation technique, and mass analyze each precursor ion mass selection window of the set within a specified cycle time. Product ion intensity and m/z measurements are produced for each window of the set using the first dissociation technique. The tandem mass spectrometer is also instructed to select, dissociate using a second dissociation technique, and mass analyze each precursor ion mass selection window of the set within the same cycle time. Product ion intensity and m/z measurements are produced for each window of the set using the second dissociation technique. Product ion measurements from both the first and second dissociation techniques are used to identify or quantitate compounds of a sample.
Patent EP-4045930-A1 (EP)
Inventor: MANOLAKOS ALEXANDROS
IPC: G01S5/02
Filed: 2020-09-18
Abstract: Methods, systems, and devices for wireless communications are described. A user equipment (UE) may receive a configuration signal from a network entity, the configuration signal indicating a configuration for a first positioning reference signal. The UE may determine one or more properties associated with the first positioning reference signal based on the configuration signal. The UE may bypass at least one portion of a transmit chain associated with a scheduled transmission of the first positioning reference signal or a receive chain associated with a scheduled reception of a second positioning reference signal. The UE may then activate, after an end of the transmission or the reception, the at least one portion of the transmit chain associated with the scheduled transmission of the first positioning reference signal or the receive chain associated with a scheduled reception of the second positioning reference signal.
Patent EP-4044813-A1 (EP)
Inventor: WACHTLER PETER
IPC: C04B111/00
Filed: 2020-10-13
Abstract: L'invention concerne un mélange fongicide comprenant les biocides TBZ et PYM selon le rapport pondéral de 20 : 1 à 1,1 : 1, en particulier 10 : 1 à 1,1 : 1, de préférence 5 : 1 à 1,1 : 1, la quantité totale de TBZ et de PYM sur la base de la quantité totale d'agents actifs biocides étant supérieure à 99 % en poids. L'invention concerne également son utilisation pour la protection de panneaux muraux.
Patent EP-3957402-A1 (EP)
Title: High-pressure fluid discharge device
Inventor: DOI YOSHITADA
IPC: F15B21/00
Filed: 2020-02-17
Abstract: This high-pressure fluid discharge device (10) has: an input port (32) through which a high-pressure fluid is fed; a tank chamber (12) which stores the high-pressure fluid; and a discharge port (60) through which the high-pressure fluid is discharged. A diaphragm valve (16) which divides a pilot chamber (58) and a valve chamber (56) communicating with the tank chamber is provided, the pilot chamber communicates with the valve chamber through a pilot passage (16c), the valve chamber communicates with the discharge port through a discharge passage (62) while the diaphragm valve is open, an opening-closing control valve (20) is provided in open flow paths (64a-64d) for opening the pilot chamber to the discharge passage, and the opening-closing control valve is opened and closed by means of the pressure of the fluid fed from the tank chamber.
Patent EP-4031648-A1 (EP)
Inventor: PHELPS MWITA
IPC: C12N5/07
Filed: 2020-09-17
Abstract: Described herein are efficiently dissolving tablets of dry cell culture media, feeds, supplements, media subgroups, buffer concentrates, or media components useful in culturing cells or microorganisms, methods of manufacturing, and methods of use. In particular, formulations of tableted cell culture media feeds, supplements, media subgroups, or buffer concentrates are described.
Patent EP-4054716-A1 (EP)
Inventor: AUGSBERGER CHRISTIAN
IPC: A61P35/00
Filed: 2020-11-03
Abstract: The present invention relates to the treatment of cancer, in particular to the treatment of cancer using a HLA-A2/WT1 x CD3 bispecific antibody and lenalidomide.
Patent EP-3962346-A1 (EP)
Inventor: DOUK NAREAK
IPC: A61M25/09
Filed: 2020-04-30
Abstract: An imaging system for a patient comprises an imaging probe. The imaging probe comprises: an elongate shaft for insertion into the patient and comprising a proximal end, a distal portion, and a lumen extending between the proximal end and the distal portion; a rotatable optical core comprising a proximal end and a distal end, and at least a portion of the rotatable optical core is positioned within the lumen of the elongate shaft; an optical assembly positioned proximate the distal end of the rotatable optical core, the optical assembly configured to direct light to tissue and collect reflected light from the tissue; a damping fluid positioned between the elongate shaft and the rotatable optical core and configured to reduce non-uniform rotation of the optical assembly; and a fluid pressurization element configured to increase the pressure of the damping fluid to reduce the presence of bubbles proximate the optical assembly.
Patent EP-3964579-A1 (EP)
Inventor: FANG RIGUO
IPC: C12N15/11
Filed: 2020-04-29
Abstract: The present invention relates to a method for treating hemoglobinopathy in an individual, comprising: (a) an evaluation step: the evaluation step comprises evaluating the ability of a first population of modified CD34-positive hematopoietic stem cells/progenitor cells to produce a desired level of γ-globin or fetal hemoglobin after differentiation, the modified CD34-positive HSPCs of the first population being derived from the individual and being modified to reduce BCL11A function; and (b) a treatment step: the treatment step comprises administering to the individual a second population of modified CD34-positive HSPCs, the modified CD34-positive HSPCs being derived from the individual and being modified to reduce BCL11A function. At the same time, the invention also relates to a method for treating hemoglobinopathy in individuals, a method for selecting individuals suffering from hemoglobinopathy for treatment using the modified CD34-positive HSPCs of the second population, and a method for determining whether an individual suffering from hemoglobinopathy is suitable or unsuitable for treatment using the second population of modified CD34-positive HSPCs derived from the individual and modified to reduce BCL11A function.